MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
0.8800
-0.0202
-2.24%
After Hours: 0.8954 +0.0154 +1.75% 19:59 12/05 EST
OPEN
0.9083
PREV CLOSE
0.9002
HIGH
0.9100
LOW
0.8600
VOLUME
1.18M
TURNOVER
--
52 WEEK HIGH
1.800
52 WEEK LOW
0.3067
MARKET CAP
51.46M
P/E (TTM)
-1.2224
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FEMY last week (1124-1128)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 11/26 21:07
PharmaCyte sells Femasys stake, sees cash position rising to $20M
TipRanks · 11/25 14:25
PharmaCyte Biotech Monetizes Femasys Stake; Cash And Securities Expected At ~$20M After Monetization, Up From $13.3M
Benzinga · 11/25 14:19
Weekly Report: what happened at FEMY last week (1117-1121)?
Weekly Report · 11/24 09:29
Femasys Initiated at Buy by Laidlaw & Co.
Dow Jones · 11/20 14:51
Femasys Price Target Announced at $6.50/Share by Laidlaw & Co.
Dow Jones · 11/20 14:51
Laidlaw & Co. Initiates Coverage On Femasys with Buy Rating, Announces Price Target of $6.5
Benzinga · 11/20 14:44
More
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.